C.11. Scientific session: From evidence to law: strengthening public health regulation in Europe and global health governance
Abstract
Evidence-informed decision-making is a core principle of public health law, yet translating evidence into legal and regulatory action remains methodologically and institutionally difficult. Evidence is needed not only to identify health problems, but also to justify intervention, select regulatory tools, assess proportionality, and support legitimacy, often under uncertainty, long causal pathways, cross-border risks, and political or normative pressures. Organized by the EUPHA Law and Public Health Section and co-organized by the EUPHA Global Health Section, this workshop examines how epidemiological, legal, policy, and foresight-oriented evidence becomes usable, persuasive, and actionable in public health regulation. Using European public health law as a starting point, it also considers how evidence-to-law challenges arise in global and non-EU contexts, especially where health risks cross borders, regulatory capacity and data infrastructure differ, and legal commitments must balance scientific evidence, equity, feasibility, sovereignty, and political negotiation. The presentations form a coherent sequence. Orsolya Varga will introduce the central question and examine how legal surveillance can identify gaps between major health burdens and EU regulatory responses. José Chen-Xu and Nour Mahrouseh will analyse how burden-of-disease estimates are reflected in EU legislative and policy texts. Henk Hilderink will discuss foresight and anticipatory governance as tools for resilient, future-oriented regulation. Tina D Purnat will bring a Global Health Section perspective on translating evidence into international health law, global health governance, and regulatory action across diverse settings. Monika Kosińska will bring the WHO perspective on how evidence on social determinants of health equity can support legal and policy responses across countries. After short presentations, a moderated discussion will ask participants to consider what distinguishes evidence of harm from evidence for action, how legal surveillance and foresight can strengthen accountability, and how evidence-to-law challenges differ across European and global health governance contexts. Participants will leave with a clearer understanding of which forms of evidence are needed to justify legal intervention and support durable, equity-oriented public health regulation.
Key messages: • Public health law needs different forms of evidence to justify fair, proportionate, and effective regulatory action.
• Effective regulation depends on turning evidence into feasible, equitable, and legally robust action across Europe and global health contexts.
Related
- K.2. Scientific session: Agency in the urban environment: From evidence to action
- M.2. Scientific session: Mind matters in maternity care: cross-country evidence on perinatal mental health (IMAgiNE Study)
- Q.11. Scientific session: Living, Researching and Providing Care in Crisis: Voices and Evidence from the Field
- P.9. Scientific session: How do we judge the trustworthiness of epidemiological research? Evidence and expert reflections
- A robot-like learning companion for executive-function neurofeedback: acceptability, user experience, and evidence of within-session self-regulation in a pilot study
BibTeX
@article{euphalawandpublichealthsection2026scientific,
title = {{C.11. Scientific session: From evidence to law: strengthening public health regulation in Europe and global health governance}},
author = {EUPHA Law and Public Health section, EUPHA Global Health section and Orsolya Varga and Mihály Kökény},
journal = {The European Journal of Public Health},
year = {2026},
month = oct,
doi = {10.1093/eurpub/ckag169.600},
url = {https://doi.org/10.1093/eurpub/ckag169.600},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - C.11. Scientific session: From evidence to law: strengthening public health regulation in Europe and global health governance
AU - EUPHA Law and Public Health section, EUPHA Global Health section
AU - Orsolya Varga
AU - Mihály Kökény
PY - 2026
DA - 2026/10/01
JO - The European Journal of Public Health
DO - 10.1093/eurpub/ckag169.600
UR - https://doi.org/10.1093/eurpub/ckag169.600
AB - Evidence-informed decision-making is a core principle of public health law, yet translating evidence into legal and regulatory action remains methodologically and institutionally difficult. Evidence is needed not only to identify health problems, but also to justify intervention, select regulatory tools, assess proportionality, and support legitimacy, often under uncertainty, long causal pathways, cross-border risks, and political or normative pressures. Organized by the EUPHA Law and Public Health Section and co-organized by the EUPHA Global Health Section, this workshop examines how epidemiological, legal, policy, and foresight-oriented evidence becomes usable, persuasive, and actionable in public health regulation. Using European public health law as a starting point, it also considers how evidence-to-law challenges arise in global and non-EU contexts, especially where health risks cross borders, regulatory capacity and data infrastructure differ, and legal commitments must balance scientific evidence, equity, feasibility, sovereignty, and political negotiation. The presentations form a coherent sequence. Orsolya Varga will introduce the central question and examine how legal surveillance can identify gaps between major health burdens and EU regulatory responses. José Chen-Xu and Nour Mahrouseh will analyse how burden-of-disease estimates are reflected in EU legislative and policy texts. Henk Hilderink will discuss foresight and anticipatory governance as tools for resilient, future-oriented regulation. Tina D Purnat will bring a Global Health Section perspective on translating evidence into international health law, global health governance, and regulatory action across diverse settings. Monika Kosińska will bring the WHO perspective on how evidence on social determinants of health equity can support legal and policy responses across countries. After short presentations, a moderated discussion will ask participants to consider what distinguishes evidence of harm from evidence for action, how legal surveillance and foresight can strengthen accountability, and how evidence-to-law challenges differ across European and global health governance contexts. Participants will leave with a clearer understanding of which forms of evidence are needed to justify legal intervention and support durable, equity-oriented public health regulation. Key messages: • Public health law needs different forms of evidence to justify fair, proportionate, and effective regulatory action. • Effective regulation depends on turning evidence into feasible, equitable, and legally robust action across Europe and global health contexts.
SN - 1101-1262
SN - 1464-360X
ER -